* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download S05 Biotechnology Gene Therapy 1
Secreted frizzled-related protein 1 wikipedia , lookup
Molecular evolution wikipedia , lookup
Gene expression wikipedia , lookup
Genome evolution wikipedia , lookup
Promoter (genetics) wikipedia , lookup
Gene desert wikipedia , lookup
Community fingerprinting wikipedia , lookup
Gene expression profiling wikipedia , lookup
Gene nomenclature wikipedia , lookup
Cell-penetrating peptide wikipedia , lookup
Genetic engineering wikipedia , lookup
List of types of proteins wikipedia , lookup
Silencer (genetics) wikipedia , lookup
Endogenous retrovirus wikipedia , lookup
Gene regulatory network wikipedia , lookup
Gene therapy of the human retina wikipedia , lookup
Artificial gene synthesis wikipedia , lookup
Gene Therapy The invention of recombinant DNA technology consequently led to the immediate inception of engineered gene transfer into human cells, aiming at reversing a cellular dysfunction or creating new cellular function. The concept of direct therapeutic benefit based on a gene defect correction in human cells or on gene therapy was born Gene therapy relies on Gene intervention Supplementing or replacing defective genes by their normal counterparts At the most basic level: the intracellular delivery of genetic material to generate a therapeutic effect by correcting an existing defect or providing cells with a new function. Initially, only the inherited genetic disorders were in focus but now a wide range of diseases, including cancer, neurodegenerative disorders vascular disease and other acquired diseases are being considered as plausible targets. The ultimate goal of gene therapy is the alleviation of disease upon a single administration of an appropriate therapeutic gene. Hurdle 1. Nucleic acids have poor cell penetration capacity. Vectors are needed Hurdle 2. Humans are equipped with very sophisticated defense systems Integration within the host genome would lead to AE Germ line vs Somatic gene therapy • Germ line therapy vs Somatic therapy Germ-line therapy aims at the introduction of genes into germ-cells or omnipotent embryonal cells (4-8 cellular stage) Considered unethical, nevertheless, lifelong correction • Somatic therapy: insertion of genes into diploid cells of an individual where the genetic material is not passed onto its progeny. Ex vivo vs In vivo gene therapy • Ex vivo: delivery is after explanation, cultivation and manipulation in vitro, followed by subsequent reimplantation. ++ minimal complicating immunological problems and enhanced efficiency of vector delivery in vitro. • In situ delivery:administering the material directly to the desired tissue is currently the major area of clinical interest )CFTR and cancer gene therapy) • In vivo delivery: systemic administration of the delivery systems. Least advanced strategy, rapid clearance mechanisms Potential targets for Gene Therapy • Inherited disorders: an intact version of the gene is introduced into these cells in which inadequate expression of the gene is determining symptom of the disease. • Not necessarily 100% correction • Stable correction is required: integration is human genome, or episomal with an origin of replication • Cystic fibrosis • CANCER TUMOR SUPPRESSOR GENE THERAPY: tumor suppressor gene such as p53 which is mutated in a large number of cancer SUICIDE GENE THERAPY: Herpes Simplex virusThymidine kinase. The enzyme phosphorylates the pro-drug ganciclovir ANTIANGIOGENIC GENE THERAPY: delivering antiangiogenic factors to the tumour vasculature. angiogenesis inhibitors that act directly on endothelial cells to cause selective apoptosis of stimulated and proliferating endothelial cells GENETIC ENHANCEMENT OF ANTITUMOR IMMUNE RESPONSES: genes which encode for artificial receptors, which, when expressed by immune cells, allow these cells to specifically recognize cancer cells thereby increasing the ability of these gene modified immune cells to kill cancer cells in the patient DRUG RESISTANCE GENE THERAPY: Expression of drug-resistance genes in hematopoietic stem cells using gene transfer methodologies holds the promise of overcoming marrow toxicity in cancer chemotherapy. Gene transfer methods The ideal vector for gene delivery would have at least the following characteristics: • specificity for the targeted cells; • resistance to metabolic degradation and/or attack by the immune system; • safety, i.e., minimal side effects; and • ability to express, in an appropriately regulated fashion, the therapeutic gene for as long as required. Gene transfer methods Non viral gene delivery Mechanical Gene Delivery a. Microinjection: the most direct method to introduce gene into cells. Either cytoplasm or nucleus. Microsurgical procedure (needle, precision positioning device, microinjector) visual inspection under microscope. Nuclear vs cytoplasmic injection Very laborious Has been used successfully for skeletal muscles b. Particle bombardment (gene gun): microparticles coated with genetic material are forcefully injected into cells delivering the functional genes. The particles must be nontoxic, non-reactive, and smaller than the diameter of the target cell (most commonly 1– 1.5 um). Naked DNA can be precipitated onto these microparticles, and is then gradually released within the cell post-bombardment. Ex vivo and in vivo could be used Non viral gene delivery Physical methods • Electroporation: very common technique, exposes the cell membrane to highintensity electrical pulses that can cause transient and localized destabilization of the barrier. Membrane gets highly permeable to exogenous substances. Electric field results in pores. Efficiency is cell dependent • Sonoporation The application of ultrasound. Different frequencies and wave forms. Cavitation causes mechanical perturbation • Laser irradiation A laser source with known energy. Focused to the cells via a lens and permeability of the cell is modified by local thermal effect Kinetics of gene therapy A key advantage of physical methods: direct gene delivery • Diffusion of plasmid is slow (size dependent) • Internalization is higher than successful transfection • Cytoplasmic degradation is possible • Electroporation: entry to nucleus is achieved • Laser irradiation: nuclear envelope is perforated • Ultrasound: acceleration to nucleus • Sonoporation: effective nuclear delivery • Gene gun: acceleration to nucleus is achieved • Non viral gene delivery 1. Naked DNA (physical and mechanical methods) 2. Polymer based gene delivery 3. Lipid based gene delivery Polymeric gene delivery • Design criteria for synthetic gene delivery 1. Neutralize negatively charged phosphate backbone of DNA to prevent charge repulsion 2. Condense the bulky structure 3. Protect DNA from extracellular and intracellular nucleases • Three packaging strategies 1. Electrostatic interaction: more than one amino group, ionized at neutral pH. Limitation: toxicity, DNA release 2. Encapsulation: within a biodegradable spherical structure. Offers protection. Limitation: formulation factors, low encapsulation efficiency, DNA release 3. Adsorption: adsorption to the surface of biodegradable particles. Surface presentation and enzymes Cationic lipids and cationic liposomes • The most extensively studied DNA carriers • Do not encapsulate DNA, form complexes • Cationic lipids are amphiphiles, cationic head attached via a linker to hydrocarbon chains • Cationic lipids assume various structural phases • Could be modified: PEG attachment: stealth, pH sensitive binding • Mostly taken up by endocytosis: pH sensitive delivery